Researchers developed a population-based cohort study to determine whether there are associations between endometriosis subtypes and incidence of ovarian cancer.
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A retrospective cohort study assessed the impact of delayed postoperative chemotherapy initiation on survival outcomes in patients with endometrial cancer, highlighting a significant association with...
A recent retrospective cohort study assessed the prevalence of germline and somatic mutations in patients with ovarian carcinosarcoma and their impact on cancer-related outcomes, highlighting the need for...
A retrospective analysis of the National Cancer Database suggests that incorporating laparoscopy before laparotomy in primary debulking surgery improves overall survival in stage IIIC epithelial ovarian...
In a retrospective analysis, researchers compared survival outcomes and prognostic factors between patients with advanced-stage epithelial ovarian cancer who underwent hyperthermic intraperitoneal...
A real-world retrospective study found that adding GLP-1 receptor agonists to hormone therapy may reduce endometrial cancer risk in women with benign uterine or endometrial hyperplasia. This study was...
A retrospective cohort study compared the patient characteristics and postoperative outcomes of those with stage III or IV epithelial ovarian cancer who had same-day discharge following minimally invasive...
In their phase 3, open-label trial, Brown and colleagues set out to address the need for more effective first-line treatment strategies for fit patients with untreated CLL.
A recent phase 3 trial showed that combining nivolumab with AVD chemotherapy improves 2-year progression-free survival while also offering a superior safety profile compared with a brentuximab vedotin...
